Tesaro investors have a $1.8 billion day - The Boston Globe

Fortune

Tesaro investors have a $1.8 billion day The Boston Globe Tesaro Inc. shareholders can be forgiven if they feel like they won the lottery. The stock more than doubled Wednesday, adding $1.8 billion in market value, after the Waltham company reported its experimental drug slowed ovarian cancer progression in a ... Tesaro shares blast off as niraparib hits progression-free survival in ovarian cancerBioWorld Online This Biotech's Stock Just Doubled and It's Bad News for SanofiFortune Tesaro Shares Surge 82% Because Drug Slows Ovarian CancerForbes TheStreet.com -FierceBiotech -Motley Fool -StreetInsider.com all 30 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNEk64O4QEuasghicUbMA63mRRmiNA&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779143737877&ei=iXZ0V_C2J43U3gGPpafABQ&url=https://www.bostonglobe.com/business/2016/06/29/tesaro-investors-have-billion-day/ZEaCG7YyiSKSK8sNDTL70N/story.html
via IFTTT